Illumina Asks Fed. Circ. To Revive Affymetrix IP Suit
Illumina Inc. on Thursday asked the Federal Circuit to overturn a decision letting genetic research company Affymetrix Inc. off the hook for claims that it infringed two patents covering gene-sequencing technology,...To view the full article, register now.
Already a subscriber? Click here to view full article